Form D — Cambrian BioPharma Inc
0000897069-25-000101 · filed Jan 13, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Reported offering amount
- $37,602,297
- Reported amount sold
- $23,022,065
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Cambrian BioPharma Inc
- CIK
- 1797409
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 228 Park Avenue South
NEW YORK, NY 10003 - Phone
- (516) 962-3186
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
James G. Peyer · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Christian Angermayer · DirectorNew York, NY Find on LinkedIn ↗
-
Maryanna Saenko · DirectorNew York, NY Find on LinkedIn ↗
-
Brenton Saunders · DirectorNew York, NY Find on LinkedIn ↗
-
Paul Farr · DirectorNew York, NY Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗